Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


Articles published in Atherosclerosis

Retrieve available abstracts of 188 articles:
HTML format



Single Articles


    September 2022
  1. NONG JC, You W, Xu T, Meng PN, et al
    Dynamic natural morphologies and component changes in nonculprit subclinical atherosclerosis in patients with acute coronary syndrome at 1-year follow-up and clinical significance at 3-year follow-up.
    Atherosclerosis. 2022;356:1-8.
    PubMed     Abstract available


    August 2022
  2. SCHIANO C, Balbi C, Burrello J, Ruocco A, et al
    De novo DNA methylation induced by circulating extracellular vesicles from acute coronary syndrome patients.
    Atherosclerosis. 2022;354:41-52.
    PubMed     Abstract available


  3. CICERO AFG, Salvetti M
    Peripheral artery disease: A highly prevalent untreated and uncontrolled independent cardiovascular disease.
    Atherosclerosis. 2022;354:55-56.
    PubMed    


  4. KUMAR R, Bainey KR
    Percutaneous coronary intervention with peripheral artery disease in the contemporary era: Still life or limb?
    Atherosclerosis. 2022;355:45-47.
    PubMed    


  5. PINXTERHUIS TH, Ploumen EH, Zocca P, Doggen CJM, et al
    Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials.
    Atherosclerosis. 2022;355:52-59.
    PubMed     Abstract available


    July 2022
  6. KIM C, Choi DW, Lee SJ, Suh Y, et al
    Benefit and risk of prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with chronic kidney disease: A nationwide cohort study.
    Atherosclerosis. 2022;352:69-75.
    PubMed     Abstract available


  7. ALFADDAGH A, Kapoor K, Dardari ZA, Bhatt DL, et al
    Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention.
    Atherosclerosis. 2022;353:11-19.
    PubMed     Abstract available


  8. AL RIFAI M, Ahmed AI, Al-Mallah MH
    Evaluating coronary atherosclerosis progression among South Asians.
    Atherosclerosis. 2022;353:30-32.
    PubMed    


  9. BHATIA HS, Lin F, Thomas IC, Denenberg J, et al
    Coronary artery calcium incidence and changes using direct plaque measurements: The MASALA study.
    Atherosclerosis. 2022;353:41-46.
    PubMed     Abstract available


  10. POST WS, Haberlen SA, Witt MD, Zhang L, et al
    Suboptimal HIV suppression is associated with progression of coronary artery stenosis: The Multicenter AIDS Cohort Study (MACS) longitudinal coronary CT angiography study.
    Atherosclerosis. 2022;353:33-40.
    PubMed     Abstract available


    June 2022
  11. KYTO V, Saraste A, Tornio A
    Early statin use and cardiovascular outcomes after myocardial infarction: A population-based case-control study.
    Atherosclerosis. 2022;354:8-14.
    PubMed     Abstract available


  12. CLARKE R, Hammami I, Sherliker P, Valdes-Marquez E, et al
    Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.
    Atherosclerosis. 2022;354:15-22.
    PubMed     Abstract available


  13. BOAKYE E, Dardari Z, Obisesan OH, Osei AD, et al
    Sex-and race-specific burden of aortic valve calcification among older adults without overt coronary heart disease: The Atherosclerosis Risk in Communities Study.
    Atherosclerosis. 2022 Jun 13. pii: S0021-9150(22)00290.
    PubMed     Abstract available


  14. CALBUREAN PA, Grebenisan P, Nistor IA, Pal K, et al
    Prediction of 3-year all-cause and cardiovascular cause mortality in a prospective percutaneous coronary intervention registry: Machine learning model outperforms conventional clinical risk scores.
    Atherosclerosis. 2022;350:33-40.
    PubMed     Abstract available


  15. ROESNER C, Goeller M, Raaz-Schrauder D, Dey D, et al
    Differences of inflammatory cytokine profile in patients with vulnerable plaque: A coronary CTA study.
    Atherosclerosis. 2022;350:25-32.
    PubMed     Abstract available


  16. GORDIN D, Bjornstad P, van Raalte DH
    Lipids in CKD: What do we actually know?
    Atherosclerosis. 2022;350:97-99.
    PubMed    


  17. SORENSEN IM, Bisgaard LS, Bjergfelt SS, Ballegaard EL, et al
    The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease.
    Atherosclerosis. 2022;350:109-118.
    PubMed     Abstract available


  18. GROENLAND EH, Heidemann BE, van der Laan SW, van Setten J, et al
    Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular disease.
    Atherosclerosis. 2022;350:102-108.
    PubMed     Abstract available


    May 2022
  19. SCHNITZER F, Forer L, Schonherr S, Gieger C, et al
    Association between a polygenic and family risk score on the prevalence and incidence of myocardial infarction in the KORA-F3 study.
    Atherosclerosis. 2022;352:10-17.
    PubMed     Abstract available


  20. WELSH RC, Kay R, Bainey KR
    Evaluation and management of chronic kidney disease patients with stable ischemic heart disease.
    Atherosclerosis. 2022 May 16. pii: S0021-9150(22)00241.
    PubMed    


  21. MATSUSHITA K, Gao Y, Sang Y, Ballew SH, et al
    Comparative mortality according to peripheral artery disease and coronary heart disease/stroke in the United States.
    Atherosclerosis. 2022 May 8. pii: S0021-9150(22)00221.
    PubMed     Abstract available


  22. WOLTERS FJ, Hilal S, Leening MJG, Kavousi M, et al
    Plasma amyloid-beta40 in relation to subclinical atherosclerosis and cardiovascular disease: A population-based study.
    Atherosclerosis. 2022;348:44-50.
    PubMed     Abstract available


  23. DANG AT, Turner AW, Lau P, Mohottalage D, et al
    A novel anti-inflammatory role links the CARS2 locus to protection from coronary artery disease.
    Atherosclerosis. 2022;348:8-15.
    PubMed     Abstract available


  24. MATSUOKA S, Kaneko H, Okada A, Itoh H, et al
    Association of retinal atherosclerosis assessed using Keith-Wagener-Barker system with incident heart failure and other atherosclerotic cardiovascular disease: Analysis of 319,501 individuals from the general population.
    Atherosclerosis. 2022;348:68-74.
    PubMed     Abstract available


  25. GRUNEIS R, Lamina C, Di Maio S, Schonherr S, et al
    The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A.
    Atherosclerosis. 2022;349:151-159.
    PubMed     Abstract available


  26. LI Q, Chen Y, Yu L, Zhu L, et al
    The relationship between lipoprotein(a) and cardiovascular events in acute coronary syndrome patients with and without chronic kidney disease.
    Atherosclerosis. 2022;349:204-210.
    PubMed     Abstract available


  27. LEE H, Park KS, Jeon YJ, Park EJ, et al
    Lipoprotein(a) and subclinical coronary atherosclerosis in asymptomatic individuals.
    Atherosclerosis. 2022;349:190-195.
    PubMed     Abstract available


    April 2022
  28. CHO IY, Yoo JE, Han K, Kim D, et al
    Frequent drinking is more predictive of ischemic stroke than binge drinking, but not of myocardial infarction.
    Atherosclerosis. 2022;350:65-72.
    PubMed     Abstract available


  29. TENG H, Gao Y, Wu C, Zhang H, et al
    Prevalence and patient characteristics of familial hypercholesterolemia in a Chinese population aged 35-75 years: Results from China PEACE Million Persons Project.
    Atherosclerosis. 2022;350:58-64.
    PubMed     Abstract available


  30. NAKAMURA H, Kataoka Y, Nicholls SJ, Puri R, et al
    Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.
    Atherosclerosis. 2022 Apr 10. pii: S0021-9150(22)00166.
    PubMed     Abstract available


  31. JUKEMA RA, de Winter RW, van Diemen PA, Driessen RS, et al
    The relation of RAAS activity and endothelin-1 levels to coronary atherosclerotic burden and microvascular dysfunction in chest pain patients.
    Atherosclerosis. 2022;347:47-54.
    PubMed     Abstract available


  32. AHMED AI, Raggi P, Al-Mallah MH
    Primary vs. secondary prevention and coronary artery calcium: Shades of grey.
    Atherosclerosis. 2022;347:68-69.
    PubMed    


  33. DZAYE O, Razavi AC, Michos ED, Mortensen MB, et al
    Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial.
    Atherosclerosis. 2022;347:70-76.
    PubMed     Abstract available


  34. MAURICIO R, Singh K, Sanghavi M, Ayers CR, et al
    Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study.
    Atherosclerosis. 2022;346:46-52.
    PubMed     Abstract available


  35. KATSIKI N, Raggi P, Korosoglou G
    Carotid ultrasound and coronary calcium for the prediction of incident cardiac disease in asymptomatic individuals: A further step towards precision medicine especially in women?
    Atherosclerosis. 2022;346:79-81.
    PubMed    


  36. YAMAGUCHI M, Hoshino M, Sugiyama T, Kanaji Y, et al
    Association of near-infrared spectroscopy-defined lipid rich plaque with lesion morphology and peri-coronary inflammation on computed tomography angiography.
    Atherosclerosis. 2022;346:109-116.
    PubMed     Abstract available


    March 2022
  37. CHO IY, Chang Y, Sung E, Kim Y, et al
    Fasting ketonuria is inversely associated with coronary artery calcification in non-diabetic individuals.
    Atherosclerosis. 2022;348:1-7.
    PubMed     Abstract available


  38. LESZEK A, Poli L, Zbinden S, Godoy LC, et al
    Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysis.
    Atherosclerosis. 2022 Mar 4. pii: S0021-9150(22)00106.
    PubMed     Abstract available


  39. CHRISTENSEN DM, Strange JE, Phelps M, Schjerning AM, et al
    Age- and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 2021.
    Atherosclerosis. 2022;346:63-67.
    PubMed     Abstract available


  40. BAJAJ R, Eggermont J, Grainger SJ, Raber L, et al
    Machine learning for atherosclerotic tissue component classification in combined near-infrared spectroscopy intravascular ultrasound imaging: Validation against histology.
    Atherosclerosis. 2022;345:15-25.
    PubMed     Abstract available


  41. ASZTALOS BF, Hauser TH, Goldfine AB, Welty FK, et al
    The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
    Atherosclerosis. 2022;345:1-6.
    PubMed     Abstract available


  42. KOBO O, Saada M, Laanmets P, Karageorgiev D, et al
    Impact of peripheral artery disease on prognosis after percutaneous coronary intervention: Outcomes from the multicenter prospective e-ULTIMASTER registry.
    Atherosclerosis. 2022;344:71-77.
    PubMed     Abstract available


  43. KOSHY AN, Nerlekar N, Gow PJ, Lim R, et al
    A prospective natural history study of coronary atherosclerosis following liver transplantation.
    Atherosclerosis. 2022;344:40-48.
    PubMed     Abstract available


  44. KUNIO M, Gardecki JA, Watanabe K, Nishimiya K, et al
    Histopathological correlation of near infrared autofluorescence in human cadaver coronary arteries.
    Atherosclerosis. 2022;344:31-39.
    PubMed     Abstract available


  45. FUJIMOTO D, Otake H, Kawamori H, Toba T, et al
    Cholesterol uptake capacity: A new measure of high-density lipoprotein functionality as a predictor of subsequent revascularization in patients undergoing percutaneous coronary intervention.
    Atherosclerosis. 2022;345:44-50.
    PubMed     Abstract available


    February 2022
  46. PASZEK E, Pociask E, Zabczyk M, Piorkowski A, et al
    Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.
    Atherosclerosis. 2022 Feb 11. pii: S0021-9150(22)00078.
    PubMed     Abstract available


  47. STONE PH, Coskun AU
    Coronary angiography-based shear stress computation to identify high-risk coronary artery plaques: Are we there yet?
    Atherosclerosis. 2022;342:25-27.
    PubMed    


  48. WENTZEL JJ, Papafaklis MI, Antoniadis AP, Takahashi S, et al
    Sex-related differences in plaque characteristics and endothelial shear stress related plaque-progression in human coronary arteries.
    Atherosclerosis. 2022;342:9-18.
    PubMed     Abstract available


  49. HULTEN EA, Gallagher RM
    Coronary revascularization for patients with non-ST elevation myocardial infarction and chronic kidney disease: Better three hours too soon than a minute too late?
    Atherosclerosis. 2022 Feb 1. pii: S0021-9150(22)00042.
    PubMed    


    January 2022
  50. GUDMUNDSSON EF, Bjornsdottir G, Sigurdsson S, Andersen K, et al
    Carotid plaque is strongly associated with coronary artery calcium and predicts incident coronary heart disease in a population-based cohort.
    Atherosclerosis. 2022 Jan 23. pii: S0021-9150(22)00043.
    PubMed     Abstract available


  51. YOSHIDA Y, Chen Z, Baudier RL, Krousel-Wood M, et al
    Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women.
    Atherosclerosis. 2022;344:13-19.
    PubMed     Abstract available


  52. HE X, Dong B, Liang W, Wu Y, et al
    Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data.
    Atherosclerosis. 2022;344:1-6.
    PubMed     Abstract available


  53. ANNEMA W, Gawinecka J, Muendlein A, Saely CH, et al
    Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease.
    Atherosclerosis. 2022;341:27-33.
    PubMed     Abstract available


  54. LEE YH, Tsai TH, Chen JH, Huang CJ, et al
    Machine learning of treadmill exercise test to improve selection for testing for coronary artery disease.
    Atherosclerosis. 2022;340:23-27.
    PubMed     Abstract available


  55. MA WF, Hodonsky CJ, Turner AW, Wong D, et al
    Enhanced single-cell RNA-seq workflow reveals coronary artery disease cellular cross-talk and candidate drug targets.
    Atherosclerosis. 2022;340:12-22.
    PubMed     Abstract available


    December 2021
  56. ZHANG H, Yi M, Wang Y, Zhang Y, et al
    Air pollution and recurrence of cardiovascular events after ST-segment elevation myocardial infarction.
    Atherosclerosis. 2021;342:1-8.
    PubMed     Abstract available


  57. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Outcome of early versus delayed invasive strategy in patients with non-ST-segment elevation myocardial infarction and chronic kidney disease not on dialysis.
    Atherosclerosis. 2021 Dec 1. pii: S0021-9150(21)01463.
    PubMed     Abstract available


  58. ZEB I, Jorgensen NW, Blumenthal RS, Burke GL, et al
    Association of inflammatory markers and lipoprotein particle subclasses with progression of coronary artery calcium: The multi-ethnic study of atherosclerosis.
    Atherosclerosis. 2021;339:27-34.
    PubMed     Abstract available


  59. DI GIORGI N, Michelucci E, Smit JM, Scholte AJHA, et al
    A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome.
    Atherosclerosis. 2021;339:1-11.
    PubMed     Abstract available


  60. DZAYE O, Berning P, Dardari ZA, Berman DS, et al
    Coronary artery calcium is associated with long-term mortality from lung cancer: Results from the Coronary Artery Calcium Consortium.
    Atherosclerosis. 2021;339:48-54.
    PubMed     Abstract available


    November 2021
  61. LOH WJ, Chang X, Aw TC, Phua SK, et al
    Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population.
    Atherosclerosis. 2021 Nov 26. pii: S0021-9150(21)01446.
    PubMed     Abstract available


  62. CANDREVA A, Pagnoni M, Rizzini ML, Mizukami T, et al
    Risk of myocardial infarction based on endothelial shear stress analysis using coronary angiography.
    Atherosclerosis. 2021 Nov 16. pii: S0021-9150(21)01437.
    PubMed     Abstract available


  63. VERDOIA M, De Luca G
    Reply to: "Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead".
    Atherosclerosis. 2021;336:49-50.
    PubMed    


  64. ZUIN M, Rigatelli G, Zuliani G, Roncon L, et al
    Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead.
    Atherosclerosis. 2021;336:48.
    PubMed    


  65. WANG FM, Yang C, Ballew SH, Kalbaugh CA, et al
    Ankle-brachial index and subsequent risk of incident and recurrent cardiovascular events in older adults: The Atherosclerosis Risk in Communities (ARIC) study.
    Atherosclerosis. 2021;336:39-47.
    PubMed     Abstract available


    October 2021
  66. MAHENDIRAN T, Klingenberg R, Nanchen D, Gencer B, et al
    CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients.
    Atherosclerosis. 2021;335:77-83.
    PubMed     Abstract available


  67. MARTINEZ-CEBALLOS MA, Sinning Rey JC, Alzate-Granados JP, Mendoza-Pinto C, et al
    Coronary calcium in autoimmune diseases: A systematic literature review and meta-analysis.
    Atherosclerosis. 2021;335:68-76.
    PubMed     Abstract available


  68. KIM H, Park JT, Lee J, Jung JY, et al
    The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease.
    Atherosclerosis. 2021;335:53-61.
    PubMed     Abstract available


  69. DOBIASOVA M
    Correspondence to: "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors".
    Atherosclerosis. 2021;335:148.
    PubMed    


  70. NEGRINI S, von Eckardstein A
    Reply to: "Correspondence to: "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors"".
    Atherosclerosis. 2021;335:149.
    PubMed    


  71. VENKATARAMAN P, Huynh Q, Nicholls SJ, Stanton T, et al
    Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trial.
    Atherosclerosis. 2021;334:57-65.
    PubMed     Abstract available


  72. HAQUE W, Grandhi GR, Kanaya AM, Kandula NR, et al
    Implications of the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines and potential value of the coronary artery calcium score among South Asians in the US: The Mediators of Atherosclerosis in South Asians Li
    Atherosclerosis. 2021;334:48-56.
    PubMed     Abstract available


  73. BAMBAGIONI G, Di Mario C, Torguson R, Demola P, et al
    Lipid-rich plaques detected by near-infrared spectroscopy predict coronary events irrespective of age: A Lipid Rich Plaque sub-study.
    Atherosclerosis. 2021;334:17-22.
    PubMed     Abstract available


  74. AHMED AI, Han Y, Al Rifai M, Alnabelsi T, et al
    Added prognostic value of plaque burden to computed tomography angiography and myocardial perfusion imaging.
    Atherosclerosis. 2021;334:9-16.
    PubMed     Abstract available


    September 2021
  75. KRISTIANSEN O, Sverre E, Peersen K, Fagerland MW, et al
    The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease.
    Atherosclerosis. 2021;336:23-29.
    PubMed     Abstract available


  76. LIU Y, Liu S, Zhao Z, Song X, et al
    Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease.
    Atherosclerosis. 2021;333:75-82.
    PubMed     Abstract available


  77. AGBAEDENG TA, Noubiap JJ, Mofo Mato EP, Chew DP, et al
    Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.
    Atherosclerosis. 2021;333:48-55.
    PubMed     Abstract available


  78. ALI HJ, Al-Mallah MH
    Time for sex specific atherosclerosis risk prediction.
    Atherosclerosis. 2021;333:87-88.
    PubMed    


  79. PEPE M, Napoli G, Carulli E, Moscarelli M, et al
    Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis?
    Atherosclerosis. 2021;333:24-31.
    PubMed     Abstract available


  80. USUI E, Matsumura M, Mintz GS, Zhou Z, et al
    Clinical outcomes of low-intensity area without attenuation and cholesterol crystals in non-culprit lesions assessed by optical coherence tomography.
    Atherosclerosis. 2021;332:41-47.
    PubMed     Abstract available


  81. VERNON ST, Kott KA, Hansen T, Zhang KJ, et al
    Coronary artery disease burden in women poorly explained by traditional risk factors: Sex disaggregated analyses from the BioHEART-CT study.
    Atherosclerosis. 2021;333:100-107.
    PubMed     Abstract available


    August 2021
  82. SATO R, Okada K, Akiyama E, Konishi M, et al
    Impact of sarcopenic obesity on long-term clinical outcomes after ST-segment elevation myocardial infarction.
    Atherosclerosis. 2021 Aug 27. pii: S0021-9150(21)01294.
    PubMed     Abstract available


  83. DYRBUS K, Gasior M, Desperak P, Trzeciak P, et al
    Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry.
    Atherosclerosis. 2021;333:16-23.
    PubMed     Abstract available


  84. SILVIS MJM, Fiolet ATL, Opstal TSJ, Dekker M, et al
    Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy.
    Atherosclerosis. 2021;334:93-100.
    PubMed     Abstract available


  85. LIU HH, Li S, Cao YX, Guo YL, et al
    Association of triglyceride-rich lipoprotein-cholesterol with recurrent cardiovascular events in statin-treated patients according to different inflammatory status.
    Atherosclerosis. 2021;330:29-35.
    PubMed     Abstract available


  86. GOUDA P, Ramasundarahettige C, Anand S, Muhlhoffer E, et al
    Clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: A post hoc analysis of the COMPASS trial.
    Atherosclerosis. 2021;331:38-44.
    PubMed     Abstract available


    July 2021
  87. DE LUCA G, Debel N, Cercek M, Jensen LO, et al
    Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry.
    Atherosclerosis. 2021;332:48-54.
    PubMed     Abstract available


  88. LIAN XJ, Dai YN, Xue JH, Zeng LH, et al
    Ticagrelor and the risk of infections during hospitalization in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
    Atherosclerosis. 2021;331:6-11.
    PubMed     Abstract available


  89. SCOCCIA A, Gallone G, Cereda A, Palmisano A, et al
    Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19.
    Atherosclerosis. 2021;328:136-143.
    PubMed     Abstract available


  90. SHIBUTANI H, Fujii K, Ueda D, Kawakami R, et al
    Automated classification of coronary atherosclerotic plaque in optical frequency domain imaging based on deep learning.
    Atherosclerosis. 2021;328:100-105.
    PubMed     Abstract available


  91. VACCARINO V, Shah AJ, Mehta PK, Pearce B, et al
    Brain-heart connections in stress and cardiovascular disease: Implications for the cardiac patient.
    Atherosclerosis. 2021;328:74-82.
    PubMed     Abstract available


  92. KOYAMA S, Yamashita A, Matsuura Y, Saito Y, et al
    Intracellular glutamine level determines vascular smooth muscle cell-derived thrombogenicity.
    Atherosclerosis. 2021;328:62-73.
    PubMed     Abstract available


  93. BOS MM, de Vries L, Rensen PC, Willems van Dijk K, et al
    Apolipoprotein E genotype, lifestyle and coronary artery disease: Gene-environment interaction analyses in the UK Biobank population.
    Atherosclerosis. 2021;328:33-37.
    PubMed     Abstract available


  94. ZHENG YY, Wu TT, Guo QQ, Chen Y, et al
    Long-term dual antiplatelet-induced intestinal injury resulting in translocation of intestinal bacteria into blood circulation increased the incidence of adverse events after PCI in patients with coronary artery disease.
    Atherosclerosis. 2021;328:1-10.
    PubMed     Abstract available


    June 2021
  95. GOLUB I, Lakshmanan S, Dahal S, Budoff MJ, et al
    Utilizing coronary artery calcium to guide statin use.
    Atherosclerosis. 2021;326:17-24.
    PubMed     Abstract available


  96. RAGGI P
    Healthy ageing to guide targeted versus universal treatment: A different approach to prevention.
    Atherosclerosis. 2021;326:45-46.
    PubMed    


  97. RAZAVI AC, Kelly TN, Budoff MJ, Bazzano LA, et al
    Atherosclerotic cardiovascular disease events among statin eligible individuals with and without long-term healthy arterial aging.
    Atherosclerosis. 2021;326:56-62.
    PubMed     Abstract available


    May 2021
  98. HONDA Y, Mok Y, Mathews L, Hof JRV, et al
    Psychosocial factors and subsequent risk of hospitalizations with peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Atherosclerosis. 2021 May 9. pii: S0021-9150(21)00223.
    PubMed     Abstract available


  99. WANG L, Zhou W, Guo M, Hua Y, et al
    The gut microbiota is associated with clinical response to statin treatment in patients with coronary artery disease.
    Atherosclerosis. 2021;325:16-23.
    PubMed     Abstract available


  100. VILAHUR G, Sutelman P, Mendieta G, Ben-Aicha S, et al
    Triglyceride-induced cardiac lipotoxicity is mitigated by Silybum marianum.
    Atherosclerosis. 2021;324:91-101.
    PubMed     Abstract available


  101. CHO H, Kang SJ, Min HS, Lee JG, et al
    Intravascular ultrasound-based deep learning for plaque characterization in coronary artery disease.
    Atherosclerosis. 2021;324:69-75.
    PubMed     Abstract available


  102. WON KB, Heo R, Park HB, Lee BK, et al
    Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors.
    Atherosclerosis. 2021;324:46-51.
    PubMed     Abstract available


    April 2021
  103. WANG Z, Wu J, Zhang D
    Hysterectomy and ischemic heart disease: An observational study using propensity score methods in NHANES 2007-2018.
    Atherosclerosis. 2021;327:5-12.
    PubMed     Abstract available


  104. BAINEY KR
    DAPT risk stratification using coronary artery angioscopy at 2 weeks: Personalized medicine at its finest?
    Atherosclerosis. 2021;322:74-76.
    PubMed    


  105. ZAFEIROPOULOS S, Farmakis I, Kartas A, Arvanitaki A, et al
    Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial.
    Atherosclerosis. 2021;323:37-43.
    PubMed     Abstract available


  106. TUFARO V, Safi H, Torii R, Koo BK, et al
    Wall shear stress estimated by 3D-QCA can predict cardiovascular events in lesions with borderline negative fractional flow reserve.
    Atherosclerosis. 2021;322:24-30.
    PubMed     Abstract available


  107. KITAHARA S, Kataoka Y, Miura H, Nishii T, et al
    The feasibility and limitation of coronary computed tomographic angiography imaging to identify coronary lipid-rich atheroma in vivo: Findings from near-infrared spectroscopy analysis.
    Atherosclerosis. 2021;322:1-7.
    PubMed     Abstract available


    March 2021
  108. KUMAR A, Giannopoulos AA, Chatzizisis YS
    The stenotic vulnerable plaque: Identifying the substrate of acute coronary syndromes.
    Atherosclerosis. 2021;320:95-97.
    PubMed    


  109. GUGLIELMO M, Lin A, Dey D, Baggiano A, et al
    Epicardial fat and coronary artery disease: Role of cardiac imaging.
    Atherosclerosis. 2021;321:30-38.
    PubMed     Abstract available


  110. ARCHER JM, Raggi P, Amin SB, Zhang C, et al
    Season and clinical factors influence epicardial adipose tissue attenuation measurement on computed tomography and may hamper its utilization as a risk marker.
    Atherosclerosis. 2021;321:8-13.
    PubMed     Abstract available


  111. NANNA MG, Peterson ED, Chiswell K, Overton RA, et al
    The incremental value of angiographic features for predicting recurrent cardiovascular events: Insights from the Duke Databank for Cardiovascular Disease.
    Atherosclerosis. 2021;321:1-7.
    PubMed     Abstract available


  112. SHI F, Sun L, Kaptoge S
    Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis.
    Atherosclerosis. 2021;320:70-78.
    PubMed     Abstract available


  113. KLINGENBERG R, Aghlmandi S, Gencer B, Nanchen D, et al
    Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events.
    Atherosclerosis. 2021;320:31-37.
    PubMed     Abstract available


  114. VARSHNEY AS, Coskun AU, Siasos G, Maynard CC, et al
    Spatial relationships among hemodynamic, anatomic, and biochemical plaque characteristics in patients with coronary artery disease.
    Atherosclerosis. 2021;320:98-104.
    PubMed     Abstract available


    February 2021
  115. KISANUKI K, Muraki I, Yamagishi K, Kokubo Y, et al
    Weight change during middle age and risk of stroke and coronary heart disease: The Japan Public Health Center-based Prospective Study.
    Atherosclerosis. 2021;322:67-73.
    PubMed     Abstract available


  116. KEDHI E, Verdoia M, Suryapranata H, Damen S, et al
    Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.
    Atherosclerosis. 2021;321:39-44.
    PubMed     Abstract available


  117. CALIGIURI G, Mallat Z
    "Plaque erosion" or the danger of eerily quiet appearance.
    Atherosclerosis. 2021;318:43-44.
    PubMed    


  118. SATO Y, Finn AV, Virmani R
    Calcified nodule: A rare but important cause of acute coronary syndrome with worse clinical outcomes.
    Atherosclerosis. 2021;318:40-42.
    PubMed    


  119. RAGGI P, Abele J
    Molecular imaging for risk prediction of coronary artery disease: A close or far fetched option?
    Atherosclerosis. 2021;319:118-120.
    PubMed    


  120. COENEN DM, Heinzmann ACA, Karel MFA, Cosemans JMEM, et al
    The multifaceted contribution of platelets in the emergence and aftermath of acute cardiovascular events.
    Atherosclerosis. 2021;319:132-141.
    PubMed     Abstract available


  121. DE WINTER RW, Schumacher SP, Stuijfzand WJ, van Diemen PA, et al
    Evolution of coronary artery calcium and absolute myocardial perfusion after percutaneous revascularization: A 3-year serial hybrid [(15)O]H2O PET/CT imaging study.
    Atherosclerosis. 2021;318:22-31.
    PubMed     Abstract available


  122. MONTONE RA, Meucci MC, De Vita A, Lanza GA, et al
    Coronary provocative tests in the catheterization laboratory: Pathophysiological bases, methodological considerations and clinical implications.
    Atherosclerosis. 2021;318:14-21.
    PubMed     Abstract available


  123. MAJEED K, Bellinge JW, Butcher SC, Alcock R, et al
    Coronary (18)F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome.
    Atherosclerosis. 2021;319:142-148.
    PubMed     Abstract available


  124. SUGANE H, Kataoka Y, Otsuka F, Nakaoku Y, et al
    Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule.
    Atherosclerosis. 2021;318:70-75.
    PubMed     Abstract available


  125. TAMARAPPOO BK, Lin A, Commandeur F, McElhinney PA, et al
    Machine learning integration of circulating and imaging biomarkers for explainable patient-specific prediction of cardiac events: A prospective study.
    Atherosclerosis. 2021;318:76-82.
    PubMed     Abstract available


  126. GREGORY FRANCK
    Role of mechanical stress and neutrophils in the pathogenesis of plaque erosion.
    Atherosclerosis. 2021;318:60-69.
    PubMed     Abstract available


  127. COLLET C, Conte E, Mushtaq S, Brouwers S, et al
    Reviewing imaging modalities for the assessment of plaque erosion.
    Atherosclerosis. 2021;318:52-59.
    PubMed     Abstract available


  128. VERGALLO R, Jang IK, Crea F
    New prediction tools and treatment for ACS patients with plaque erosion.
    Atherosclerosis. 2021;318:45-51.
    PubMed     Abstract available


    January 2021
  129. OHGAKU A, Fukamachi D, Takahashi K, Tamiya R, et al
    Absence of coronary angioscopy-derived in-stent thrombi is associated with major bleeding events in acute myocardial infarction.
    Atherosclerosis. 2021;319:62-71.
    PubMed     Abstract available


  130. GERMAN CA, Shapiro MD
    Statins and coronary artery calcium: What's the score?
    Atherosclerosis. 2021;316:71-72.
    PubMed    


  131. AUER J, Auer L
    Stent selection in patients with NSTEMI and risk of incident heart failure.
    Atherosclerosis. 2021;316:66-68.
    PubMed    


  132. AL RIFAI M, Kanaya AM, Kandula NR, Cainzos-Achirica M, et al
    Distribution of calcium volume, density, number, and type of coronary vessel with calcified plaque in South Asians in the US and other race/ethnic groups: The MASALA and MESA studies.
    Atherosclerosis. 2021;317:16-21.
    PubMed     Abstract available


  133. GAO Y, Lou Y, Liu Y, Wu S, et al
    The relationship between residual cholesterol risk and plaque characteristics in patients with acute coronary syndrome: Insights from an optical coherence tomography study.
    Atherosclerosis. 2021;317:10-15.
    PubMed     Abstract available


  134. HEFFRON SP, Ruuth MK, Xia Y, Hernandez G, et al
    Low-density lipoprotein aggregation predicts adverse cardiovascular events in peripheral artery disease.
    Atherosclerosis. 2021;316:53-57.
    PubMed     Abstract available


  135. BITTNER DO, Goeller M, Dey D, Zopf Y, et al
    High levels of eicosapentaenoic acid are associated with lower pericoronary adipose tissue attenuation as measured by coronary CTA.
    Atherosclerosis. 2021;316:73-78.
    PubMed     Abstract available


  136. OSEI AD, Mirbolouk M, Berman D, Budoff MJ, et al
    Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The coronary artery calcium consortium.
    Atherosclerosis. 2021;316:79-83.
    PubMed     Abstract available


    December 2020
  137. SVENDSEN K, Krogh HW, Igland J, Tell GS, et al
    2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia.
    Atherosclerosis. 2020;319:28-34.
    PubMed     Abstract available


  138. ZDANYTE M, Wrazidlo RW, Kaltenbach S, Groga-Bada P, et al
    Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores.
    Atherosclerosis. 2020;318:1-7.
    PubMed     Abstract available


  139. PURSNANI S, Merchant M
    South Asian ethnicity as a risk factor for coronary heart disease.
    Atherosclerosis. 2020;315:126-130.
    PubMed     Abstract available


  140. OORNI K, Jauhiainen M, Kovanen PT
    Why and how increased plasma ceramides predict future cardiovascular events?
    Atherosclerosis. 2020;314:71-73.
    PubMed    


  141. GUPTA M
    Addressing atherosclerotic cardiovascular disease risk in South Asians: A daunting task ahead.
    Atherosclerosis. 2020;315:76-78.
    PubMed    


    November 2020
  142. PEREZ DE ISLA L, Alonso R, Gomez de Diego JJ, Muniz-Grijalvo O, et al
    Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study.
    Atherosclerosis. 2020 Nov 18. pii: S0021-9150(20)31521.
    PubMed     Abstract available


  143. KEDHI E, Delewi R, Fabris E, De Luca G, et al
    Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials.
    Atherosclerosis. 2020;315:55-61.
    PubMed     Abstract available


    October 2020
  144. LIN CF, Chang YH, Yu FC, Tsai CT, et al
    Risk of heart failure following drug-eluting stent implantation in patients with non-ST-elevation myocardial infarction.
    Atherosclerosis. 2020 Oct 10. pii: S0021-9150(20)30575.
    PubMed     Abstract available


  145. BELL S, Gibson JT, Harshfield EL, Markus HS, et al
    Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study.
    Atherosclerosis. 2020;313:111-117.
    PubMed     Abstract available


  146. GAMBARDELLA J, Wang X, Mone P, Khondkar W, et al
    Genetics of adrenergic signaling drives coronary artery calcification.
    Atherosclerosis. 2020;310:88-90.
    PubMed    


  147. VAN ROSENDAEL AR, Cainzos-Achirica M, Al-Mallah MH
    Calcified plaque morphology, density, and risk.
    Atherosclerosis. 2020;311:100-102.
    PubMed    


    September 2020
  148. CHALIKIAS G, Serif L, Thomaidis A, Lantzouraki A, et al
    Comparison of novel LDL cholesterol equations in myocardial infarction patients: Clinical impact on risk re-classification and lipid treatment goals on secondary prevention.
    Atherosclerosis. 2020;313:96-101.
    PubMed     Abstract available


  149. LIU X, Wu S, Song Q, Wang X, et al
    Visit-to-visit variability of lipid measurements and the risk of myocardial infarction and all-cause mortality: A prospective cohort study.
    Atherosclerosis. 2020 Sep 9. pii: S0021-9150(20)30493.
    PubMed     Abstract available


  150. ZHANG M, Liu HH, Jin JL, Yan XN, et al
    Lipoprotein(a) and cardiovascular death in oldest-old (>/=80 years) patients with acute myocardial infarction: A prospective cohort study.
    Atherosclerosis. 2020;312:54-59.
    PubMed     Abstract available


  151. LANGSTED A, Bojesen SE, Stroes ESG, Nordestgaard BG, et al
    AHRR hypomethylation as an epigenetic marker of smoking history predicts risk of myocardial infarction in former smokers.
    Atherosclerosis. 2020;312:8-15.
    PubMed     Abstract available


  152. MAJEED K, Hillis GS, Schultz CJ
    A "light based biopsy" for high-risk atherosclerotic plaque.
    Atherosclerosis. 2020;309:65-66.
    PubMed    


  153. BARTON DE, Hamilos M, Chatzizisis YS
    Left main percutaneous coronary intervention versus coronary artery bypass surgery: A case of true equivalence in low and intermediate complexity anatomy or a question yet to be answered?
    Atherosclerosis. 2020;308:45-47.
    PubMed    


    August 2020
  154. SHITOLE SG, Kuniholm MH, Hanna DB, Boucher T, et al
    Association of human immunodeficiency virus and hepatitis C virus infection with long-term outcomes post-ST segment elevation myocardial infarction in a disadvantaged urban community.
    Atherosclerosis. 2020;311:60-66.
    PubMed     Abstract available


  155. SHROFF GR, Sanchez OA, Miedema MD, Kramer H, et al
    Coronary artery calcium progresses rapidly and discriminates incident cardiovascular events in chronic kidney disease regardless of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2020;310:75-82.
    PubMed     Abstract available


  156. BELLASI A, Di Lullo L, Raggi P
    Is peritoneal dialysis superior to hemodialysis as far as cardiovascular risk? Another unsolved dilemma for maintenance dialysis.
    Atherosclerosis. 2020;307:75-77.
    PubMed    


    July 2020
  157. FUKUMOTO K, Takemoto Y, Yoshikawa J, Norioka N, et al
    Predictors of endothelial function improvement in patients with mild hypertriglyceridemia without evidence of coronary artery disease treated with purified eicosapentaenoic acid.
    Atherosclerosis. 2020;309:27-32.
    PubMed     Abstract available


  158. GULIZIA MM, Maggioni AP, Abrignani MG, Bilato C, et al
    Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Atherosclerosis. 2020;308:32-38.
    PubMed     Abstract available


    May 2020
  159. SENONER T, Plank F, Barbieri F, Beyer C, et al
    Added value of high-risk plaque criteria by coronary CTA for prediction of long-term outcomes.
    Atherosclerosis. 2020;300:26-33.
    PubMed     Abstract available


  160. DE NISCO G, Hoogendoorn A, Chiastra C, Gallo D, et al
    The impact of helical flow on coronary atherosclerotic plaque development.
    Atherosclerosis. 2020;300:39-46.
    PubMed     Abstract available


    April 2020
  161. BJERRE M, Hilden J, Winkel P, Jensen GB, et al
    Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy.
    Atherosclerosis. 2020;301:8-14.
    PubMed     Abstract available


  162. CHEN Q, Li Q, Li D, Chen X, et al
    Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease.
    Atherosclerosis. 2020;299:45-52.
    PubMed     Abstract available


  163. KARJALAINEN MK, Holmes MV, Wang Q, Anufrieva O, et al
    Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study.
    Atherosclerosis. 2020;299:56-63.
    PubMed     Abstract available


    March 2020
  164. PANG J, Abraham A, Vargas-Garcia C, Bates TR, et al
    An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemia.
    Atherosclerosis. 2020;298:52-57.
    PubMed     Abstract available


  165. MORELLI MB, Santulli G, Gambardella J
    Calcium supplements: Good for the bone, bad for the heart? A systematic updated appraisal.
    Atherosclerosis. 2020;296:68-73.
    PubMed    


  166. MAZIDI M, Katsiki N, Mikhailidis DP, Banach M, et al
    Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies.
    Atherosclerosis. 2020;296:49-58.
    PubMed     Abstract available


  167. ADINOLFI LE, Petta S, Fracanzani AL, Coppola C, et al
    Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study.
    Atherosclerosis. 2020;296:40-47.
    PubMed     Abstract available


  168. SIMONETTO C, Heier M, Rospleszcz S, Meisinger C, et al
    Risk for cardiovascular events responds nonlinearly to carotid intima-media thickness in the KORA F4 study.
    Atherosclerosis. 2020;296:32-39.
    PubMed     Abstract available


  169. ANZIC DROFENIK A, Vrtovec M, Bozic Mijovski M, Sever M, et al
    Progression of coronary calcium burden and carotid stiffness in patients with essential thrombocythemia associated with JAK2 V617F mutation.
    Atherosclerosis. 2020;296:25-31.
    PubMed     Abstract available


  170. LESKELA RL, Torvinen A, Rissanen TT, Virtanen V, et al
    Outcomes of lipid control in secondary prevention of coronary artery disease in Finland: A 24-month follow-up after acute coronary syndrome.
    Atherosclerosis. 2020;296:4-10.
    PubMed     Abstract available


  171. LUNDE NN, Gregersen I, Ueland T, Shetelig C, et al
    Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages.
    Atherosclerosis. 2020;296:74-82.
    PubMed     Abstract available


  172. GUARALDI G, Milic J, Prandini N, Ligabue G, et al
    (18)Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients.
    Atherosclerosis. 2020;297:127-135.
    PubMed     Abstract available


  173. LIM SS, Yang YL, Chen SC, Wu CH, et al
    Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
    Atherosclerosis. 2020;297:40-46.
    PubMed     Abstract available


  174. THEN C, Then HL, Lechner A, Thorand B, et al
    Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study.
    Atherosclerosis. 2020;297:1-7.
    PubMed     Abstract available


    February 2020
  175. MIRBOLOUK M, Kianoush S, Dardari Z, Miedema MD, et al
    The association of coronary artery calcium score and mortality risk among smokers: The coronary artery calcium consortium.
    Atherosclerosis. 2020;294:33-40.
    PubMed     Abstract available


  176. MUSCOGIURI G, Chiesa M, Trotta M, Gatti M, et al
    Performance of a deep learning algorithm for the evaluation of CAD-RADS classification with CCTA.
    Atherosclerosis. 2020;294:25-32.
    PubMed     Abstract available


  177. BLAHA MJ, Cainzos-Achirica M, Dardari Z, Blankstein R, et al
    All-cause and cause-specific mortality in individuals with zero and minimal coronary artery calcium: A long-term, competing risk analysis in the Coronary Artery Calcium Consortium.
    Atherosclerosis. 2020;294:72-79.
    PubMed     Abstract available


    January 2020
  178. CHICHAREON P, Modolo R, Kogame N, Takahashi K, et al
    Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study.
    Atherosclerosis. 2020;295:45-53.
    PubMed     Abstract available


  179. BONELLO-PALOT N, Laine M, Cuisset T, Ronchard T, et al
    High prevalence of mutations in perilipin 1 in patients with precocious acute coronary syndrome.
    Atherosclerosis. 2020;293:86-91.
    PubMed     Abstract available


  180. ALKHALIL M
    Effects of intensive lipid-lowering therapy on mortality after coronary bypass surgery: A meta-analysis of 7 randomised trials.
    Atherosclerosis. 2020;293:75-78.
    PubMed     Abstract available


  181. LEIHERER A, Ebner J, Muendlein A, Brandtner EM, et al
    High betatrophin in coronary patients protects from cardiovascular events.
    Atherosclerosis. 2020;293:62-68.
    PubMed     Abstract available


  182. UELAND T, Akerblom A, Ghukasyan T, Michelsen AE, et al
    ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial.
    Atherosclerosis. 2020;293:35-41.
    PubMed     Abstract available


  183. LEE JG, Ko J, Hae H, Kang SJ, et al
    Intravascular ultrasound-based machine learning for predicting fractional flow reserve in intermediate coronary artery lesions.
    Atherosclerosis. 2020;292:171-177.
    PubMed     Abstract available


  184. KIMURA S, Sugiyama T, Hishikari K, Nakagama S, et al
    Relationship of systemic pentraxin-3 values with coronary plaque components on optical coherence tomography and post-percutaneous coronary intervention outcomes in patients with stable angina pectoris.
    Atherosclerosis. 2020;292:127-135.
    PubMed     Abstract available


  185. MUNOZ-TORRERO JFS, Zamorano J, Rico-Martin S, Rivas MD, et al
    Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease.
    Atherosclerosis. 2020;292:84-89.
    PubMed     Abstract available


  186. MANCIO J, Barros AS, Conceicao G, Pessoa-Amorim G, et al
    Epicardial adipose tissue volume and annexin A2/fetuin-A signalling are linked to coronary calcification in advanced coronary artery disease: Computed tomography and proteomic biomarkers from the EPICHEART study.
    Atherosclerosis. 2020;292:75-83.
    PubMed     Abstract available


  187. COUSELO-SEIJAS M, Agra-Bermejo RM, Fernandez AL, Martinez-Cereijo JM, et al
    High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment.
    Atherosclerosis. 2020;292:60-69.
    PubMed     Abstract available


  188. SANDESARA PB, Mehta A, O'Neal WT, Kelli HM, et al
    Clinical significance of zero coronary artery calcium in individuals with LDL cholesterol >/=190mg/dL: The Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2020;292:224-229.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: